CD4 and systemic lupus erythematosus: In concordance to the aberrant T cells activation in SLE, pristane injection into hu-mice induced the activation of both CD4+ T cells and CD8+ T cells, as shown by accumulation of CCR7−CD45RA− effector memory cells, and increased expression of HLA-DR, a human-specific lymphocyte activation marker (Fig. 5).